Gritstone Bio Inc logo

Gritstone Bio Inc

$ 3.26 -0.07 (-2.1%) 10:08 PM EST
P/E:
At Loss
P/B:
1.74
Market Cap:
$ 271.77M
Enterprise V:
$ 180.16M
Volume:
898.48K
Avg Vol (2M):
1.38M
Also Trade In:
Volume:
898.48K
Market Cap $:
271.77M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.38M
Enterprise Value $:
180.16M
PB Ratio:
1.74

Business Description

Description
Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, BiSAb, among others.
Name Current Vs Industry Vs History
Cash-To-Debt 3.3
Equity-to-Asset 0.67
Debt-to-Equity 0.31
Debt-to-EBITDA -0.38
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.04
Distress
Grey
Safe
Beneish M-Score -3.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 52.39
9-Day RSI 51.06
14-Day RSI 50.58
6-1 Month Momentum % 8.41
12-1 Month Momentum % -32.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.75
Quick Ratio 4.75
Cash Ratio 4.33

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -33.8

Financials (Next Earnings Date:2023-03-10 Est.)

GRTS's 30-Y Financials

How Gritstone Bio Inc (GRTS) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GRTS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 9.722
EPS (TTM) ($) -1.39
Beta 0.29
Volatility % 74.32
14-Day RSI 50.58
14-Day ATR ($) 0.234052
20-Day SMA ($) 3.224
12-1 Month Momentum % -32.25
52-Week Range ($) 1.71 - 6.1
Shares Outstanding (Mil) 83.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gritstone Bio Inc Filings

Document Form Filing Date
No Filing Data

Gritstone Bio Inc Stock Events

Event Date Price($)
No Event Data

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1